Efficacy and safety of the selective aldosterone blocker eplerenone in Japanese patients with hypertension: a randomized, double-blind, placebo-controlled, dose-ranging study.

Journal of clinical hypertension (Greenwich, Conn.)

Volumn 6, Issue 4, 2004, Pages

  Saruta, Takao ^a   Kageyama, Shigeru ^a   Ogihara, Toshio ^a   Hiwada, Kunio ^a   Ogawa, Masayo ^a   Tawara, Kazuji ^a   Gatlin, Marjorie ^a   Garthwaite, Susan ^a   Bittman, Richard ^a   Patrick, Jeffrey ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; DIURETIC AGENT; DRUG DERIVATIVE; EPLERENONE; PLACEBO; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; JAPAN; MALE; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SAFETY; TREATMENT OUTCOME;

ADULT; AGED; ALDOSTERONE ANTAGONISTS; DIURETICS; FEMALE; HUMANS; HYPERTENSION; JAPAN; MALE; MIDDLE AGED; PLACEBOS; SAFETY; SPIRONOLACTONE; TREATMENT OUTCOME;

EID: 3442881073     PISSN: 15246175     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-6175.2004.03146.x     Document Type: Article

References (0)